Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
Abstract Background The Ki-67 Labelling Index (LI) is used as an ancillary tool in glioma diagnostics. Interobserver variability has been reported and no precise guidelines are available. Nor is it known whether novel digital approaches would be an advantage. Our aim was to evaluate the inter- and i...
Main Authors: | Ljudmilla A. G. Nielsen, Julie A. Bangsø, Kim H. Lindahl, Rikke H. Dahlrot, Jacob v. B. Hjelmborg, Steinbjørn Hansen, Bjarne W. Kristensen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-018-0711-2 |
Similar Items
-
Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells
by: Rikke H. Dahlrot, et al.
Published: (2021-09-01) -
An Update on Neurofibromatosis Type 1-Associated Gliomas
by: Mina Lobbous, et al.
Published: (2020-01-01) -
Expression of P53 and Ki-67 in Different Grades of Astrocytomas
by: Rania Rifat Abdel-Maqsoud Mohamed, et al.
Published: (2022-07-01) -
Ultrasound-guided versus traditional surgical resection of supratentorial gliomas in a limited-resources neurosurgical setting
by: Aly Ibrahim, et al.
Published: (2018-11-01) -
Cerebrospinal Fluid Drop Metastases of Canine Glioma: Magnetic Resonance Imaging Classification
by: R. Timothy Bentley, et al.
Published: (2021-05-01)